Selected article for: "different potency and infection duration"
Author: Ashish Goyal; E. Fabian Cardozo-Ojeda; Joshua T Schiffer
Title: Potency and timing of antiviral therapy as determinants of duration of SARS CoV-2 shedding and intensity of inflammatory response
  • Document date: 2020_4_14
    • ID: d7stppv5_103
    Snippet: is the (which was not peer-reviewed) The copyright holder for this preprint . Fig S4. Treatment projections of hydroxychloroquine assuming different potency and timing of treatment. Each set of simulations is performed under assumptions of high, medium and low potency. Treatment initiation is at timepoints generally consistent with a. hospitalization (day 10 after first positive sample), b. first symptoms (day 5 after first positive sample), c. p.....
    Document: is the (which was not peer-reviewed) The copyright holder for this preprint . Fig S4. Treatment projections of hydroxychloroquine assuming different potency and timing of treatment. Each set of simulations is performed under assumptions of high, medium and low potency. Treatment initiation is at timepoints generally consistent with a. hospitalization (day 10 after first positive sample), b. first symptoms (day 5 after first positive sample), c. presymptomatic post-peak phase (day 2 after first positive sample) and d. pre-symptomatic pre-peak phase (day 0). Overall, early potent treatment limits duration of infection. Heatmaps comparing variance in drug potency measured by in vivo EC50 (x-axis) and timing of treatment initiation (y-axis) for e. Shedding duration, f. viral load area under the curve (AUC) and g. extent of T cell response required for viral elimination.

    Search related documents:
    Co phrase search for related documents
    • positive sample 10 day hospitalization and pre symptomatic pre peak phase: 1, 2, 3, 4
    • positive sample 10 day hospitalization and Shedding duration: 1
    • positive sample 10 day hospitalization and timing different potency: 1
    • positive sample 10 day hospitalization and treatment initiation: 1, 2, 3, 4, 5
    • positive sample 10 day hospitalization and treatment initiation timing: 1
    • positive sample 10 day hospitalization and treatment timing different potency: 1
    • positive sample 10 day hospitalization and viral elimination: 1
    • positive sample 10 day hospitalization and viral load: 1
    • positive sample 10 day hospitalization and viral load area: 1
    • pre peak phase and Shedding duration: 1, 2
    • pre peak phase and timing different potency: 1
    • pre peak phase and treatment initiation: 1, 2, 3, 4, 5
    • pre peak phase and treatment initiation timing: 1
    • pre peak phase and treatment timing different potency: 1
    • pre peak phase and viral elimination: 1
    • pre peak phase and viral load: 1
    • pre peak phase and viral load area: 1
    • pre symptomatic pre peak phase and timing different potency: 1
    • pre symptomatic pre peak phase and treatment initiation: 1, 2, 3, 4